Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

SANOFI SA (SNY)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following business segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals32,88886.3%32,27986.5% -1.85%
Vaccines5,23513.7%5,05213.5% -3.49%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States13,51535.5%13,67736.6% +1.19%
Western Europe5,79215.2%---
Asia (Excluding Pacific Region)3,90310.2%---
Latin America3,3638.8%2,7637.4% -17.85%
Eastern Europe and Turkey2,6116.8%---
France2,4816.5%2,4356.5% -1.86%
Africa and Middle-East2,4526.4%---
Japan2,2455.9%1,8635% -17%
Other920.452.4%771.542.1% -16.18%
Rest of the World839.892.2%991.192.7% +18.01%
Europe--7,14519.1%-
Asia (Excluding South Asia)--3,4329.2%-
Africa, Middle East and South Asia--3,0518.2%-
Eurasia--1,2033.2%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD622015Chief Executive Officer & Director
Serge Weinberg672009Chairman
Jérôme Contamine612009Chief Financial Officer & Executive VP-Finance
Elias A. Zerhouni, MD672011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA512016Executive Vice President-Medical Affairs
Robert Castaigne, PhD722000Independent Director
Claudie Haigneré MD, PhD612008Independent Director
Carole Piwnica602010Independent Director
Suet-Fern Lee602011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,254,019,904 1,112,370,850 88.7% 5,000,000 0.4% 88.7%
Shareholders
NameEquities%
Dodge & Cox 62,080,354 2.46%
Barrow, Hanley, Mewhinney & Strauss LLC 22,378,817 0.89%
Franklin Advisers, Inc. 20,588,292 0.82%
Fisher Asset Management LLC 14,500,758 0.57%
Boston Partners Global Investors, Inc. 8,472,489 0.34%
Fidelity Management & Research Co. 8,009,040 0.32%
Invesco Advisers, Inc. 6,388,759 0.25%
Hotchkis & Wiley Capital Management LLC 5,799,045 0.23%
Berkshire Hathaway, Inc. (Investment Management) 3,878,524 0.15%
Managed Account Advisors LLC 3,746,424 0.15%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals (REGN) 23,880,53722.6%8,755,798,891 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,554,13410.7%1,371,826,337 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%1,082,631,283 USD
Zentiva SA (ROSCD) 312,341,64974.9%285,364,701 USD
Myokardia Inc (MYOK) 4,018,89911.2%207,375,188 USD
Sanofi (SAN) 2,115,4660.17%187,425,507 USD
Sanofi Aventis Pakistan Limited 5,099,46952.9%75,166,581 USD
JHL Biotech Inc (6540) 28,415,11112.9%58,827,804 USD
Voyager Therapeutics Inc (VYGR) 2,416,7707.52%49,882,133 USD
SCYNEXIS Inc (SCYX) 1,677,0575.87%2,985,161 USD
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA-7.30%100 380
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%224 785
PFIZER-2.84%216 135
ROCHE HOLDING LTD.-9.37%207 160
MERCK AND COMPANY-0.50%153 359
AMGEN3.23%133 241
BRISTOL-MYERS SQUIBB COMPANY6.64%112 867
ABBOTT LABORATORIES2.12%104 732
NOVO NORDISK A/S-8.76%100 546
SANOFI-11.62%100 380
BAYER-6.36%99 934
GLAXOSMITHKLINE-1.67%90 511
ELI LILLY AND COMPANY-8.80%86 953
ASTRAZENECA-7.96%83 789
CELGENE CORPORATION-9.55%71 652
ALLERGAN PLC1.86%54 557
TAKEDA PHARMACEUTICAL CO LTD-8.03%44 203
SHIRE-18.46%39 732
JIANGSU HENGRUI MEDICINE CO LTD4.28%32 119
ASTELLAS PHARMA INC5.10%29 473
Connections : Sanofi SA
Piasa SA
Académie des Technologies
Madrigall SA
Fondation C.Génial
Weinberg Capital Partners SAS
International Bar Association
Big Red, Inc.
Council on Foreign Relations, Inc.
Total Upstream UK Ltd.
Sanofi-Aventis Europe SAS
Fondation pour l’Université de Lyon
Sanofi-Aventis Participations SA
Maremma SASU
Piasa Holding SAS
Rickmers Maritime
NAXOS Capital Managers SARL
Sanofi-Aventis U.S. LLC
Pharmaceutical Research & Manufacturers of America
Financière Piasa SAS
Sanofi Pasteur Holding SA
National Committee on United States-China Relations, Inc.
Sanofi Pasteur Holding Ltd.
Omnium Insurance & Reinsurance Co. Ltd.
Fondation Lacoste
Academie de l'air et de l'espace
L'Oréal Corporate Foundation
Naxos UK Ltd.
Academie des Sports
Research!America
Académie des Sciences et Technologies
King Abdullah University of Science & Technology
i2O Water Ltd.
Warp Drive Bio LLC
Elevance Renewable Sciences, Inc.
Académie Nationale de Médecine
National Academy of Engineering
Select Music & Video Distribution Ltd.
Institute of Medicine
New York State Bar Association
Rickmers Trust Management Pte Ltd.
Morgan Lewis Stamford LLC
The Johns Hopkins University
AXA Group Solutions
Nanyang Technological University
International Federation of Pharmaceutical Manufacturers
Stamford Corporate Services Pte Ltd.
World Justice Project
AXA Asia SAS
The Children's Aid Society, Inc.
Singapore Bar
Total Gestion Filiales
Singapore Academy of Law
© 2018 People , Fundamentals and Ownership